REIMAGINING ANTIBODY MEDICINES Trademark
Trademark Overview
On Monday, March 20, 2023, a trademark application was filed for REIMAGINING ANTIBODY MEDICINES with the United States Patent and Trademark Office. The USPTO has given the REIMAGINING ANTIBODY MEDICINES trademark a serial number of 97846922. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, December 11, 2023. This trademark is owned by IGM Biosciences, Inc.. The REIMAGINING ANTIBODY MEDICINES trademark is filed in the Advertising, Business and Retail Services and Education & Entertainment Services categories with the following description:
Education services, including arranging and conducting educational congresses in the field of antibodies and antibody research and development
Providing financial and investment information in the field of antibodies and antibody research and development, including preparing reports relating to finance and investments for business purposes
General Information
| Serial Number | 97846922 |
| Word Mark | REIMAGINING ANTIBODY MEDICINES |
| Filing Date | Monday, March 20, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, December 11, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Education services, including arranging and conducting educational congresses in the field of antibodies and antibody research and development |
| Goods and Services | Providing financial and investment information in the field of antibodies and antibody research and development, including preparing reports relating to finance and investments for business purposes |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 11, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, September 15, 2022 |
| First Use In Commerce Date | Thursday, September 15, 2022 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 11, 2023 |
| Primary Code | 041 |
| First Use Anywhere Date | Thursday, September 15, 2022 |
| First Use In Commerce Date | Thursday, September 15, 2022 |
Trademark Owner History
| Party Name | IGM Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Mountain View, CA 94043 |
Trademark Events
| Event Date | Event Description |
| Thursday, March 23, 2023 | NEW APPLICATION ENTERED |
| Monday, December 11, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, April 11, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 11, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, December 11, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, December 11, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 21, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, June 10, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 21, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
